Literature DB >> 9353619

The prevention and treatment of obesity. Application to type 2 diabetes.

C A Maggio1, F X Pi-Sunyer.   

Abstract

Entities:  

Mesh：

Year:  1997        PMID： 9353619     DOI： 10.2337/diacare.20.11.1744

Source DB:  PubMed          Journal:  Diabetes Care        ISSN： 0149-5992            Impact factor:   19.112


× No keyword cloud information.
  46 in total

1.  Intentional weight loss and 13-year diabetes incidence in overweight adults.

Authors:  Julie C Will; David F Williamson; Earl S Ford; Eugenia E Calle; Michael J Thun
Journal:  Am J Public Health       Date:  2002-08       Impact factor: 9.308

2.  APOA2 -256T>C polymorphism interacts with saturated fatty acids intake to affect anthropometric and hormonal variables in type 2 diabetic patients.

Authors:  Marjan Ghane Basiri; Gity Sotoudeh; Ehsan Alvandi; Mahmood Djalali; Mohammad Reza Eshraghian; Neda Noorshahi; Fariba Koohdani
Journal:  Genes Nutr       Date:  2015-04-23       Impact factor: 5.523

3.  Modifications of coronary risk factors.

Authors:  Jeanine Albu; Sheldon H Gottlieb; Phyllis August; Richard W Nesto; Trevor J Orchard
Journal:  Am J Cardiol       Date:  2006-04-19       Impact factor: 2.778

4.  The Value of Elderly Disease Prevention.

Authors:  Dana P Goldman; David M Cutler; Baoping Shang; Geoffrey F Joyce
Journal:  Forum Health Econ Policy       Date:  2006-01

Review 5.  Orlistat: in the prevention and treatment of type 2 diabetes mellitus.

Authors:  G M Keating; B Jarvis
Journal:  Drugs       Date:  2001       Impact factor: 9.546

Review 6.  Skeletal muscle triglyceride: marker or mediator of obesity-induced insulin resistance in type 2 diabetes mellitus?

Authors:  Bret H Goodpaster; David E Kelley
Journal:  Curr Diab Rep       Date:  2002-06       Impact factor: 4.810

7.  Living Well with Diabetes: a randomized controlled trial of a telephone-delivered intervention for maintenance of weight loss, physical activity and glycaemic control in adults with type 2 diabetes.

Authors:  Elizabeth G Eakin; Marina M Reeves; Alison L Marshall; David W Dunstan; Nicholas Graves; Genevieve N Healy; Jonathan Bleier; Adrian G Barnett; Trisha O'Moore-Sullivan; Anthony Russell; Ken Wilkie
Journal:  BMC Public Health       Date:  2010-08-03       Impact factor: 3.295

8.  Weight loss, glycemic control, and changes in cardiovascular biomarkers in patients with type 2 diabetes receiving incretin therapies or insulin in a large cohort database.

Authors:  Edward S Horton; Cheryl Silberman; Keith L Davis; Rachele Berria
Journal:  Diabetes Care       Date:  2010-05-11       Impact factor: 19.112

9.  Effects of weight loss intervention on erectile function in older men with type 2 diabetes in the Look AHEAD trial.

Authors:  Rena R Wing; Raymond C Rosen; Joseph L Fava; Judy Bahnson; Frederick Brancati; Isaias Noel C Gendrano Iii; Abbas Kitabchi; Stephen H Schneider; Thomas A Wadden
Journal:  J Sex Med       Date:  2009-08-17       Impact factor: 3.802

10.  Improved treatment satisfaction and weight-related quality of life with exenatide once weekly or twice daily.

Authors:  J H Best; K S Boye; R R Rubin; D Cao; T H Kim; M Peyrot
Journal:  Diabet Med       Date:  2009-07       Impact factor: 4.359
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.